Serous Tubal Intraepithelial Carcinoma

2

Review clinical trials related to Serous Tubal Intraepithelial Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The objective of this study is to identify exposures as well as clinical, molecular, and pathological changes that can be used to predict early development of cancer, malignant transformation, and risks of progression to symptomatic cancer that can ultimately be fatal. * The ultimate goal is to identify novel markers of early detection and risk stratification to drive potential therapeutic approaches to intercept progression to cancer.

Participants needed: 5,000
Trial details
Biological sex: AllType: ObservationalSponsor: Dana-Farber Cancer InstituteUpdated: Aug 7, 2025Locations: 1Duration: 20 Years
Eligibility criteria

Carriers of known or previously unrecognized pathogenic germline variants of can... [+22]

Status: Not yet recruiting

International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

To prospectively assess the incidence of peritoneal carcinomatosis for women with isolated STIC (serous tubal intraepithelial carcinoma). Moreover, to identify histopathological characteristics of STIC which are reproducible and associated to the risk of peritoneal carcinomatosis and to report the findings of additional diagnostics.

Participants needed: 600
Trial details
Age: 18-100Biological sex: FemaleType: ObservationalSponsor: Radboud University Medical CenterUpdated: May 1, 2024Duration: 10 Years
Eligibility criteria

Women [+2]

Invasive cancer at initial surgery or pathological examination (either macroscop...